Galeon

Galeon (GALEON) stands out as a high-utility Decentralized Science (DeSci) project with tangible real-world adoption, distinguishing it from purely speculative assets. Its strongest pillars are its Team and Governance (9/10) and Security (9/10). The project is led by a fully doxxed, medically experienced team operating a registered French company since 2016, and the platform has secured clean audits from top-tier firms like CertiK and Hacken. The Market and Use Case (8.2/10) is also robust; unlike many competitors, Galeon has successfully deployed its Electronic Health Record software in 18 hospitals, serving over 10,000 caregivers, and utilizes 'Blockchain Swarm Learning' to solve critical medical data privacy issues. However, the investment case is tempered by Active Development (6/10) and Tokenomics (6.8/10). The proprietary, closed-source nature of the code limits independent verification of development velocity, although roadmap execution is visible. More critically, with only ~20.5% of the supply circulating, investors face inflationary pressure from scheduled unlocks through 2026. Despite these structural risks, the project's organic, utility-driven community and buyback-and-burn mechanism funded by real revenue create a solid foundation for long-term growth.